{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:28:59Z","timestamp":1789576139905,"version":"build-2803163510"},"reference-count":145,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBERCV CB16\/11\/00483"],"award-info":[{"award-number":["CIBERCV CB16\/11\/00483"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Horizon Europe ERA4HEALTH CARDINNOV","award":["PCI2024-153490"],"award-info":[{"award-number":["PCI2024-153490"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is strong evidence that hypertension is a major risk factor for heart failure (HF). Hypertension contributes to incident HF through direct and indirect effects. Indirect effects are consequences of ischaemic heart disease because hypertension facilitates atherosclerotic obstructive coronary artery disease. The direct effects are straightly related to hypertensive heart disease (HHD). Hypertensive heart disease poses a significant challenge with substantial medical and public health implications. Efforts should be made to recognize and manage HHD in a timely manner and optimize hypertension treatment. Reducing blood pressure (BP) and\/or reassessing antihypertensive therapy using traditional or novel approaches can halt or delay progression to HF in patients with HHD and possibly prevent it. However, HHD\u2019s importance as a risk factor for overt HF is often overlooked in clinical practice. This document aims to summarize the current understanding of the burden of HHD and its risk for incident HF, discuss the mechanisms underlying HHD-related HF onset and progression, consider how diagnostic tools contribute to individualized phenotyping and HF risk stratification of HHD, address how therapeutic measures ameliorating or even preventing structural and functional alterations of HHD, along with BP control influence HHD-associated HF risk.<\/jats:p>","DOI":"10.1093\/ejhf\/xuag004","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:45:56Z","timestamp":1767789956000},"page":"217-232","source":"Crossref","is-referenced-by-count":1,"title":["An expert opinion on heart failure in hypertensive heart disease"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3414-6919","authenticated-orcid":false,"given":"Javier","family":"D\u00edez","sequence":"first","affiliation":[{"name":"Program of Cardiovascular Diseases, Center of Applied Medical Research (CIMA) and School of Medicine, University of Navarra , Pamplona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-6528","authenticated-orcid":false,"given":"Arantxa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, Center of Applied Medical Research (CIMA) and School of Medicine, University of Navarra , Pamplona ,","place":["Spain"]},{"name":"Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health , Madrid ,","place":["Spain"]},{"name":"Department of Cardiology and Cardiac Surgery, University of Navarra Clinic, and Navarra Institute for Health Research (IdiSNA) , Pamplona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8580-9359","authenticated-orcid":false,"given":"Annet","family":"Kirabo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center , Nashville, TN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-8936","authenticated-orcid":false,"given":"Paolo","family":"Verdecchia","sequence":"additional","affiliation":[{"name":"Associazione Umbra Cuore e Ipertensione and Department of Cardiology, Hospital S. Maria della Misericordia , Perugia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazeen H","family":"Jafar","sequence":"additional","affiliation":[{"name":"Program in Health Services & Systems Research, Duke-NUS Medical School ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4533-1722","authenticated-orcid":false,"given":"Dagfinn","family":"Aune","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London , London ,","place":["UK"]},{"name":"Department of Nutrition, Oslo New University College , Oslo ,","place":["Norway"]},{"name":"Department of Research Cancer Registry of Norway, Norwegian Institute of Public Health , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke J","family":"Laffin","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation , Cleveland, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6373-9820","authenticated-orcid":false,"given":"Thilo","family":"Burkard","sequence":"additional","affiliation":[{"name":"Medical Outpatient Department and Hypertension Centre, ESH Hypertension Centre of Excellence, University Hospital Basel , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe M","family":"Rosano","sequence":"additional","affiliation":[{"name":"Department of Human Sciences and Promotion of Quality of Life, San Raffaele Open University of Rome , Rome ,","place":["Italy"]},{"name":"Cardiology, IRCCS Raffaele , Cassino ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Piepoli","sequence":"additional","affiliation":[{"name":"Clinical Cardiology, IRCCS Policlinico San Donato , Milan ,","place":["Italy"]},{"name":"Department of Biomedical Sciences for Health, University of Milan , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Mark","family":"Richards","sequence":"additional","affiliation":[{"name":"Christchurch Heart Institute, University of Otago , Christchurch ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, Center of Applied Medical Research (CIMA) and School of Medicine, University of Navarra , Pamplona ,","place":["Spain"]},{"name":"Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5926-5677","authenticated-orcid":false,"given":"Susana","family":"Ravassa","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, Center of Applied Medical Research (CIMA) and School of Medicine, University of Navarra , Pamplona ,","place":["Spain"]},{"name":"Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin W L","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Heart Centre Singapore, Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4107-2583","authenticated-orcid":false,"given":"Franz H","family":"Messerli","sequence":"additional","affiliation":[{"name":"Kantonsspital Luzern, University of Bern, Bern ,","place":["Switzerland"]},{"name":"Jagiellonian University , Krakow ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H","family":"Marwick","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute , Melbourne ,","place":["Australia"]},{"name":"Menzies Institute for Medical Research , Hobart ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8669-6410","authenticated-orcid":false,"given":"Miguel","family":"Camafort","sequence":"additional","affiliation":[{"name":"Hypertension Unit and Heart Failure Unit, Department of Internal Medicine, Hospital Clinic, University of Barcelona, Barcelona ,","place":["Spain"]},{"name":"Center for Biomedical Research in Pathophysiology of Obesity and Nutrition (CIBEROBN), Carlos III Institute of Health , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-9881","authenticated-orcid":false,"given":"Giovanni","family":"de Simone","sequence":"additional","affiliation":[{"name":"Department of Medicine, The New York Presbyterian Hospital, Weil Cornell Medicine , New York, NY ,","place":["USA"]},{"name":"Department of Advanced Biomedical Sciences, Federico II University , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Heart Failure Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-275X","authenticated-orcid":false,"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Michigan School of Medicine , Ann Arbor, MI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6235-5152","authenticated-orcid":false,"given":"Marijana","family":"Tadic","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin II, Universit\u00e4tsklinikum Ulm , Ulm ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7689-478X","authenticated-orcid":false,"given":"Cesare","family":"Cuspidi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University Milano-Bicocca , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Universit\u00e9 de Lorraine , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-8568","authenticated-orcid":false,"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Cardiology, Vita-salute San Raffaele University and IRCCS San Raffaele Hospital , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-2514","authenticated-orcid":false,"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III and HOMICAREM-Homburg Institute for CardioRenalMetabolic Medicine, Universit\u00e4tsklinikum des Saarlandes, Saarland University , Homburg\/Saar ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7683-4720","authenticated-orcid":false,"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Baylor Scott and White Research Institute , Dallas, TX ,","place":["USA"]},{"name":"University of Mississippi , Jackson, MS ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"2026051117354992000_xuag004-B1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","journal-title":"Lancet"},{"key":"2026051117354992000_xuag004-B2","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1002\/ehf2.14915","article-title":"Global trends in heart failure from 1990 to 2019: an age-period-cohort analysis from the Global Burden of Disease study","volume":"11","author":"Liu","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026051117354992000_xuag004-B3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","journal-title":"Lancet"},{"key":"2026051117354992000_xuag004-B4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/eurjpc\/zwad344","article-title":"Blood pressure, hypertension, and the risk of heart failure: a systematic review and meta-analysis of cohort studies","volume":"31","author":"Baffour","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026051117354992000_xuag004-B5","doi-asserted-by":"publisher","first-page":"e22671","DOI":"10.1016\/j.heliyon.2023.e22671","article-title":"Global, regional, and national burdens of hypertensive heart disease from 1990 to 2019: a multilevel analysis based on the global burden of Disease Study 2019","volume":"9","author":"Hu","year":"2023","journal-title":"Heliyon"},{"key":"2026051117354992000_xuag004-B6","doi-asserted-by":"publisher","first-page":"1205475","DOI":"10.3389\/fcvm.2023.1205475","article-title":"Hypertensive heart disease: risk factors, complications and mechanisms","volume":"10","author":"Masenga","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026051117354992000_xuag004-B7","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.3390\/jcm12175723","article-title":"Hypertensive heart disease: a narrative review series-part 2: macrostructural and functional abnormalities","volume":"12","author":"Nemtsova","year":"2023","journal-title":"J Clin Med"},{"key":"2026051117354992000_xuag004-B8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/ehjqcco\/qcac088","article-title":"Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990-2019","volume":"9","author":"Wei","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026051117354992000_xuag004-B9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/HYPERTENSIONAHA.120.16483","article-title":"Worldwide trends in prevalence, mortality, and disability-adjusted life years for hypertensive heart disease from 1990 to 2017","volume":"77","author":"Dai","year":"2021","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B10","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B11","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026051117354992000_xuag004-B12","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1161\/CIR.0000000000001356","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"152","author":"Jones","year":"2025","journal-title":"Circulation"},{"key":"2026051117354992000_xuag004-B13","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026051117354992000_xuag004-B14","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026051117354992000_xuag004-B15","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026051117354992000_xuag004-B16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijcard.2017.07.101","article-title":"Heart failure with mid-range ejection fraction in patients admitted to internal medicine departments: findings from the RICA Registry","volume":"255","author":"Guisado-Espartero","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026051117354992000_xuag004-B17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: heart failure epidemiology and outcomes statistics. An updated 2024 report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"key":"2026051117354992000_xuag004-B18","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","article-title":"Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017","volume":"28","author":"Bragazzi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026051117354992000_xuag004-B19","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021","volume":"403","author":"GBD 2021 Forecasting Collaborators","year":"2024","journal-title":"Lancet"},{"key":"2026051117354992000_xuag004-B20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","article-title":"The transition from hypertension to heart failure: contemporary update","volume":"5","author":"Messerli","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026051117354992000_xuag004-B21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40885-021-00186-y","article-title":"Role of strain echocardiography in patients with hypertension","volume":"28","author":"Oh","year":"2022","journal-title":"Clin Hypertens"},{"key":"2026051117354992000_xuag004-B22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacc.2017.06.046","article-title":"Geometry as a confounder when assessing ventricular systolic function: comparison between ejection fraction and strain","volume":"70","author":"Stokke","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026051117354992000_xuag004-B23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamacardio.2019.0052","article-title":"Myocardial strain in the assessment of patients with heart failure: a review","volume":"4","author":"Marwick","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026051117354992000_xuag004-B24","doi-asserted-by":"publisher","first-page":"107230","DOI":"10.1016\/j.vph.2023.107230","article-title":"Hypertension, coronary artery disease and myocardial ischemic syndromes","volume":"153","author":"Volpe","year":"2023","journal-title":"Vascul Pharmacol"},{"key":"2026051117354992000_xuag004-B25","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/jcm12072606","article-title":"Hypertensive heart disease: a narrative review series-part 1: pathophysiology and microstructural changes","volume":"12","author":"Nemtsova","year":"2023","journal-title":"J Clin Med"},{"key":"2026051117354992000_xuag004-B26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.118.11125","article-title":"Myocardial remodeling in hypertension. Toward a new view of hypertensive heart disease","volume":"72","author":"Gonz\u00e1lez","year":"2018","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cvr\/cvaa023","article-title":"Coronary microvascular dysfunction in hypertrophy and heart failure","volume":"116","author":"Camici","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2026051117354992000_xuag004-B28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"2026051117354992000_xuag004-B29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/jch.12282","article-title":"Left atrial enlargement in the early stage of hypertensive heart disease: a common but ignored condition","volume":"16","author":"Su","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026051117354992000_xuag004-B30","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1097\/HJH.0b013e32834a98db","article-title":"Left atrial size in hypertension and stroke","volume":"29","author":"Piotrowski","year":"2011","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/ajh\/hpt001","article-title":"Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies","volume":"26","author":"Cuspidi","year":"2013","journal-title":"Am J Hypertens"},{"key":"2026051117354992000_xuag004-B32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/01.hyp.0000052830.02773.e4","article-title":"Atrial fibrillation in hypertension: predictors and outcome","volume":"41","author":"Verdecchia","year":"2003","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.amjcard.2018.04.053","article-title":"Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey)","volume":"122","author":"Erk\u00fcner","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026051117354992000_xuag004-B34","doi-asserted-by":"publisher","first-page":"9G","DOI":"10.1016\/s0002-9149(03)00227-3","article-title":"Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target","volume":"91","author":"Healey","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026051117354992000_xuag004-B35","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1540-8167.2011.02125.x","article-title":"Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation","volume":"22","author":"Medi","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026051117354992000_xuag004-B36","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s41598-024-51875-1","article-title":"The relationship of atrial fibrillation with left atrial size in patients with essential hypertension","volume":"14","author":"Saadeh","year":"2024","journal-title":"Sci Rep"},{"key":"2026051117354992000_xuag004-B37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.37349\/emed.2022.00080","article-title":"Incident atrial fibrillation and heart failure in treated hypertensive patients with left ventricular hypertrophy. The LIFE study","volume":"3","author":"Bang","year":"2022","journal-title":"Explor Med"},{"key":"2026051117354992000_xuag004-B38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.123.21708","article-title":"Myocardial interstitial fibrosis in hypertensive heart disease: from mechanisms to clinical management","volume":"81","author":"Gonz\u00e1lez","year":"2024","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B39","doi-asserted-by":"publisher","first-page":"13294","DOI":"10.3390\/ijms252413294","article-title":"Systemic and cardiac microvascular dysfunction in hypertension","volume":"25","author":"Durante","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026051117354992000_xuag004-B40","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/eurheartj\/ehu436","article-title":"Mitochondrial injury and dysfunction in hypertension-induced cardiac damage","volume":"35","author":"Eirin","year":"2014","journal-title":"Eur Heart J"},{"key":"2026051117354992000_xuag004-B41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s0008-6363(03)00498-x","article-title":"Cardiomyocyte apoptosis in hypertensive cardiomyopathy","volume":"59","author":"Gonz\u00e1lez","year":"2003","journal-title":"Cardiovasc Res"},{"key":"2026051117354992000_xuag004-B42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1053\/eupc.2000.0110","article-title":"Arrhythmogenic mechanisms in left ventricular hypertrophy","volume":"2","author":"Wolk","year":"2000","journal-title":"Europace"},{"key":"2026051117354992000_xuag004-B43","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.amjcard.2014.07.015","article-title":"Meta-analysis of left ventricular hypertrophy and sustained arrhythmias","volume":"114","author":"Chatterjee","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026051117354992000_xuag004-B44","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/HYPERTENSIONAHA.119.12684","article-title":"Sudden cardiac death in hypertensive patients","volume":"73","author":"Verdecchia","year":"2019","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B45","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/hr.2017.75","article-title":"The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins","volume":"40","author":"Leggio","year":"2017","journal-title":"Hypertens Res"},{"key":"2026051117354992000_xuag004-B46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and nonischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ Res"},{"key":"2026051117354992000_xuag004-B47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.31083\/j.rcm2502072","article-title":"Molecular mechanisms underlying vascular remodeling in hypertension","volume":"25","author":"Zeng","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"2026051117354992000_xuag004-B48","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1161\/01.hyp.23.5.600","article-title":"Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults","volume":"23","author":"de Simone","year":"1994","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B49","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.hfc.2019.06.003","article-title":"Hypertensive heart disease and obesity: a review","volume":"15","author":"Saliba","year":"2019","journal-title":"Heart Fail Clin"},{"key":"2026051117354992000_xuag004-B50","doi-asserted-by":"publisher","first-page":"133182","DOI":"10.1016\/j.ijcard.2025.133182","article-title":"Pathophysiology of heart failure with preserved ejection fraction in overweight and obesity\u2014clinical and treatment implications","volume":"430","author":"Rodrigues","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026051117354992000_xuag004-B51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1161\/CIRCIMAGING.123.015051","article-title":"Impact of diabetes on myocardial fibrosis in patients with hypertension: the REMODEL study","volume":"16","author":"Pua","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026051117354992000_xuag004-B52","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/jhh.2016.88","article-title":"Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network","volume":"31","author":"Mancusi","year":"2017","journal-title":"J Hum Hypertens"},{"key":"2026051117354992000_xuag004-B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41371-022-00751-4","article-title":"Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations","volume":"37","author":"Law","year":"2022","journal-title":"J Hum Hypertens"},{"key":"2026051117354992000_xuag004-B54","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41371-021-00507-6","article-title":"Characterisation of hypertensive heart disease: pathological insights from a sudden cardiac death cohort to inform clinical practice","volume":"36","author":"Westaby","year":"2022","journal-title":"J Hum Hypertens"},{"key":"2026051117354992000_xuag004-B55","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1093\/eurheartj\/ehac393","article-title":"Phenotyping the hypertensive heart","volume":"43","author":"Tadic","year":"2022","journal-title":"Eur Heart J"},{"key":"2026051117354992000_xuag004-B56","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1097\/00004872-200208000-00014","article-title":"Change in cardiovascular risk profile by echocardiography in low- or medium-risk hypertension","volume":"20","author":"Schillaci","year":"2002","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B57","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/ehjci\/jev076","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)","volume":"16","author":"Marwick","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026051117354992000_xuag004-B58","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/HJH.0000000000000477","article-title":"Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities","volume":"33","author":"de Simone","year":"2015","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B59","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1097\/HJH.0000000000001717","article-title":"Three-dimensional echocardiographic ventricular mass\/end-diastolic volume ratio in native hypertensive patients: relation between stroke volume and geometry","volume":"36","author":"Lembo","year":"2018","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/01.hyp.35.2.580","article-title":"Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension","volume":"35","author":"Schillaci","year":"2000","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B61","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1097\/HJH.0000000000000618","article-title":"The relationship between left ventricular deformation and different geometric patterns according to the updated classification: findings from the hypertensive population","volume":"33","author":"Tadic","year":"2015","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B62","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"key":"2026051117354992000_xuag004-B63","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10741-018-9698-8","article-title":"The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more?","volume":"23","author":"Tadic","year":"2018","journal-title":"Heart Fail Rev"},{"key":"2026051117354992000_xuag004-B64","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s10741-020-09943-x","article-title":"Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus","volume":"26","author":"Tadic","year":"2021","journal-title":"Heart Fail Rev"},{"key":"2026051117354992000_xuag004-B65","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/diagnostics13010137","article-title":"Cardiac magnetic resonance in hypertensive heart disease: time for a new chapter","volume":"13","author":"Zdravkovic","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026051117354992000_xuag004-B66","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jcmg.2015.06.007","article-title":"Association of a 4-tiered classification of LV hypertrophy with adverse CV outcomes in the general population","volume":"8","author":"Garg","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026051117354992000_xuag004-B67","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1097\/HJH.0000000000002504","article-title":"Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease","volume":"38","author":"Pichler","year":"2020","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12968-015-0176-3","article-title":"Extracellular volume quantification in isolated hypertension\u2014changes at the detectable limits?","volume":"17","author":"Treibel","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026051117354992000_xuag004-B69","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1007\/s00330-017-4841-9","article-title":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling","volume":"27","author":"Wang","year":"2017","journal-title":"Eur Radiol"},{"key":"2026051117354992000_xuag004-B70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/HJH.0000000000001875","article-title":"Extracellular volume by cardiac magnetic resonance is associated with biomarkers of inflammation in hypertensive heart disease","volume":"37","author":"Pan","year":"2019","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B71","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcmg.2014.09.020","article-title":"Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone","volume":"8","author":"Kuruvilla","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026051117354992000_xuag004-B72","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1161\/HYPERTENSIONAHA.122.19225","article-title":"Markers of focal and diffuse nonischemic myocardial fibrosis are associated with adverse cardiac remodeling and prognosis in patients with hypertension: the REMODEL study","volume":"79","author":"Iyer","year":"2022","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B73","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCIMAGING.108.838367","article-title":"Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo","volume":"2","author":"Moreo","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026051117354992000_xuag004-B74","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.amjcard.2010.05.036","article-title":"Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy","volume":"106","author":"Puntmann","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026051117354992000_xuag004-B75","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/eurjpc\/zwaf083","article-title":"Global prevalence of myocardial fibrosis among individuals with cardiometabolic conditions: a systematic review and meta-analysis","volume":"32","author":"Yeo","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026051117354992000_xuag004-B76","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jcmg.2023.03.021","article-title":"Cardiac computed tomography for quantification of myocardial extracellular volume fraction: a systematic review and meta-analysis","volume":"16","author":"Han","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026051117354992000_xuag004-B77","doi-asserted-by":"publisher","first-page":"e002649","DOI":"10.1161\/JAHA.115.002649","article-title":"Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction","volume":"5","author":"Kato","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026051117354992000_xuag004-B78","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1093\/eurheartj\/ehab610","article-title":"Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure","volume":"41","author":"Zhou","year":"2022","journal-title":"Eur Heart J"},{"key":"2026051117354992000_xuag004-B79","doi-asserted-by":"publisher","first-page":"e006619","DOI":"10.1161\/JAHA.117.006619","article-title":"\u201cMalignant\u201d left ventricular hypertrophy identifies subjects at high risk for progression to asymptomatic left ventricular dysfunction, heart failure, and death: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"7","author":"Peters","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026051117354992000_xuag004-B80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamacardio.2018.4300","article-title":"Association of cardiac injury and malignant left ventricular hypertrophy with risk of heart failure in African Americans: the Jackson Heart Study","volume":"4","author":"Pandey","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026051117354992000_xuag004-B81","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.jacc.2022.08.735","article-title":"Intensive blood pressure lowering in patients with malignant left ventricular hypertrophy","volume":"80","author":"Ascher","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026051117354992000_xuag004-B82","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/01.cir.104.3.286","article-title":"Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients","volume":"104","author":"L\u00f3pez","year":"2001","journal-title":"Circulation"},{"key":"2026051117354992000_xuag004-B83","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"key":"2026051117354992000_xuag004-B84","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.1987.252.1.C1","article-title":"Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass","volume":"252","author":"Laurent","year":"1987","journal-title":"Am J Physiol"},{"key":"2026051117354992000_xuag004-B85","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1146\/annurev.biochem.77.032207.120833","article-title":"Collagen structure and stability","volume":"78","author":"Shoulders","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"2026051117354992000_xuag004-B86","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jacc.2015.10.063","article-title":"Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure","volume":"67","author":"L\u00f3pez","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026051117354992000_xuag004-B87","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/HYPERTENSIONAHA.112.196113","article-title":"Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase","volume":"60","author":"L\u00f3pez","year":"2012","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B88","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/HJH.0000000000001258","article-title":"Phenotyping of myocardial fibrosis in hypertensive patients with heart failure influence on clinical outcome","volume":"35","author":"Ravassa","year":"2017","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B89","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/HYPERTENSIONAHA.123.21725","article-title":"Randomized clinical outcome trials in hypertension","volume":"81","author":"Mancia","year":"2024","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B90","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/HJH.0000000000000848","article-title":"Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure\u2013meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B91","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"2026051117354992000_xuag004-B92","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejim.2022.03.032","article-title":"Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis","volume":"101","author":"Reboldi","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2026051117354992000_xuag004-B93","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/HJH.0000000000000378","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B94","doi-asserted-by":"publisher","first-page":"e1006","DOI":"10.1161\/CIR.0000000000001307","article-title":"Risk-based primary prevention of heart failure: a scientific statement from the American Heart Association","volume":"151","author":"Khan","year":"2025","journal-title":"Circulation"},{"key":"2026051117354992000_xuag004-B95","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.cardfail.2025.06.013","article-title":"The continuum of prevention and heart failure in cardiovascular medicine: a joint scientific statement from the Heart Failure Society of America and The American Society for Preventive Cardiology","volume":"24","author":"Lala","year":"2025","journal-title":"J Card Fail"},{"key":"2026051117354992000_xuag004-B96","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejim.2024.10.011","article-title":"Two recent European guidelines on hypertension","volume":"130","author":"Verdecchia","year":"2024","journal-title":"Eur J Intern Med"},{"key":"2026051117354992000_xuag004-B97","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"2026051117354992000_xuag004-B98","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/S0895-7061(98)00149-6","article-title":"Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents","volume":"11","author":"Schlaich","year":"1998","journal-title":"Am J Hypertens"},{"key":"2026051117354992000_xuag004-B99","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/HYPERTENSIONAHA.109.136655","article-title":"Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies","volume":"54","author":"Fagard","year":"2009","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B100","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"2026051117354992000_xuag004-B101","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/HYPERTENSIONAHA.109.138529","article-title":"Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction","volume":"55","author":"Solomon","year":"2010","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B102","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/HJH.0000000000003079","article-title":"Effect of long-term antihypertensive therapy on myocardial strain: a meta-analysis","volume":"40","author":"Tadic","year":"2022","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B103","doi-asserted-by":"publisher","first-page":"102922","DOI":"10.1016\/j.cpcardiol.2024.102922","article-title":"The future of hypertension pharmacotherapy: ongoing and future clinical trials for hypertension","volume":"50","author":"Mansoor","year":"2025","journal-title":"Curr Probl Cardiol"},{"key":"2026051117354992000_xuag004-B104","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1161\/CIRCULATIONAHA.124.072417","article-title":"Future of antihypertensive therapies","volume":"150","author":"Laffin","year":"2024","journal-title":"Circulation"},{"key":"2026051117354992000_xuag004-B105","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11906-025-01342-7","article-title":"Blood pressure lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists","volume":"27","author":"Siddiqi","year":"2025","journal-title":"Curr Hypertens Rep"},{"key":"2026051117354992000_xuag004-B106","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.jacc.2025.08.036","article-title":"Central adiposity or hypertension: which drives heart failure with a preserved ejection fraction?","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026051117354992000_xuag004-B107","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/s0895-7061(03)01018-5","article-title":"Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis","volume":"16","author":"Verdecchia","year":"2003","journal-title":"Am J Hypertens"},{"key":"2026051117354992000_xuag004-B108","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/ajh.2010.80","article-title":"Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis","volume":"23","author":"Pierdomenico","year":"2010","journal-title":"Am J Hypertens"},{"key":"2026051117354992000_xuag004-B109","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1016\/j.ijcard.2012.06.084","article-title":"Left ventricular hypertrophy reduction and clinical events. A meta-regression analysis of 14 studies in 12,809 hypertensive patients","volume":"167","author":"Costanzo","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026051117354992000_xuag004-B110","doi-asserted-by":"publisher","first-page":"e004152","DOI":"10.1161\/JAHA.116.004152","article-title":"Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network)","volume":"6","author":"L\u00f8nnebakken","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026051117354992000_xuag004-B111","doi-asserted-by":"publisher","first-page":"e000144","DOI":"10.1161\/JAHA.113.000144","article-title":"Lack of reduction of left ventricular mass in treated hypertension: the strong heart study","volume":"2","author":"de Simone","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026051117354992000_xuag004-B112","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00059-003-2524-6","article-title":"Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension retrospective analysis of 120 patients with left ventricular endomyocardial biopsies","volume":"28","author":"Brilla","year":"2003","journal-title":"Herz"},{"key":"2026051117354992000_xuag004-B113","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/s0008-6363(99)00432-0","article-title":"Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs","volume":"46","author":"Brilla","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2026051117354992000_xuag004-B114","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1161\/01.cir.0000017264.66561.3d","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"D\u00edez","year":"2002","journal-title":"Circulation"},{"key":"2026051117354992000_xuag004-B115","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1161\/01.hyp.36.2.220","article-title":"Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease","volume":"36","author":"Schwartzkopff","year":"2000","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B116","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12872-020-01553-7","article-title":"Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain","volume":"20","author":"Niu","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2026051117354992000_xuag004-B117","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1291\/hypres.28.351","article-title":"Protective effects of an angiotensin II receptor blocker and a long-acting calcium channel blocker against cardiovascular organ injuries in hypertensive patients","volume":"28","author":"Ishimitsu","year":"2005","journal-title":"Hypertens Res"},{"key":"2026051117354992000_xuag004-B118","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1097\/HJH.0b013e3282170ada","article-title":"Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)","volume":"25","author":"M\u00fcller-Brunotte","year":"2007","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B119","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1161\/HYPERTENSIONAHA.122.19134","article-title":"Cardiac structure and function across the spectrum of aldosteronism: the Atherosclerosis Risk in Communities study","volume":"79","author":"Brown","year":"2022","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B120","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"2026051117354992000_xuag004-B121","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ejhf.3141","article-title":"Reassessing the management of hypertension: time to prevent aldosterone-mediated heart failure","volume":"26","author":"Pitt","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026051117354992000_xuag004-B122","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/hjh.0000000000003430","article-title":"Effect of sacubitril\/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension","volume":"41","author":"Chen","year":"2023","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B123","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1093\/eurheartj\/ehx525","article-title":"The effect of sacubitril\/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active controlled study","volume":"38","author":"Schmieder","year":"2017","journal-title":"Eur Heart J"},{"key":"2026051117354992000_xuag004-B124","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1038\/s41467-025-62203-0","article-title":"Effects of sacubitril\/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial","volume":"16","author":"Lee","year":"2025","journal-title":"Nat Commun"},{"key":"2026051117354992000_xuag004-B125","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1038\/s41440-024-01755-y","article-title":"Renal denervation for hypertensive heart disease and atrial fibrillation","volume":"47","author":"Shinohara","year":"2024","journal-title":"Hypertens Res"},{"key":"2026051117354992000_xuag004-B126","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1097\/HJH.0000000000001798","article-title":"Regression of organ damage following renal denervation in resistant hypertension: a meta-analysis","volume":"36","author":"Kordalis","year":"2018","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B127","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/HYPERTENSIONAHA.109.130492","article-title":"Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone","volume":"54","author":"Jin","year":"2009","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B128","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.amjcard.2015.02.008","article-title":"Effect of dietary sodium and potassium intake on left ventricular diastolic function and mass in adults \u226440 years (from the Strong Heart Study)","volume":"115","author":"Haring","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026051117354992000_xuag004-B129","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11906-015-0588-3","article-title":"Influence of physical activity on hypertension and cardiac structure and function","volume":"17","author":"Hegde","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"2026051117354992000_xuag004-B130","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/HYPERTENSIONAHA.108.126805","article-title":"Endurance training in the spontaneously hypertensive rat. Conversion of pathological into physiological cardiac hypertrophy","volume":"53","author":"Garciarena","year":"2009","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B131","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1590\/s100-979x2010007500117","article-title":"Exercise training and detraining modify the morphological and mechanical properties of single cardiac myocytes obtained from spontaneously hypertensive rats","volume":"43","author":"Carneiro-J\u00fanior","year":"2010","journal-title":"Braz J Med Biol Res"},{"key":"2026051117354992000_xuag004-B132","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/0002-9149(85)90156-0","article-title":"Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity","volume":"55","author":"Alpert","year":"1985","journal-title":"Am J Cardiol"},{"key":"2026051117354992000_xuag004-B133","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/j.1550-8528.1998.tb00374.x","article-title":"Effects of obesity and weight loss on cardiac function and valvular performance","volume":"6","author":"Karason","year":"1998","journal-title":"Obes Res"},{"key":"2026051117354992000_xuag004-B134","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJM198602063140602","article-title":"The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients","volume":"314","author":"MacMahon","year":"1986","journal-title":"N Engl J Med"},{"key":"2026051117354992000_xuag004-B135"},{"key":"2026051117354992000_xuag004-B136","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/00004872-200106000-00017","article-title":"Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy","volume":"19","author":"Mureddu","year":"2001","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B137","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.hyp.0000034740.99323.8a","article-title":"Prognosis of inappropriate left ventricular mass in hypertension: the MAVI study","volume":"40","author":"de Simone","year":"2002","journal-title":"Hypertension"},{"key":"2026051117354992000_xuag004-B138","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/ejhf.3347","article-title":"Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases","volume":"26","author":"Seferovi\u0107","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026051117354992000_xuag004-B139","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41581-022-00576-x","article-title":"Cardiac metabolic remodelling in chronic kidney disease","volume":"18","author":"Patel","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"2026051117354992000_xuag004-B140","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/ehjdh\/ztaf003","article-title":"Comparison of machine learning and conventional criteria in detecting left ventricular hypertrophy and prognosis with electrocardiography","volume":"6","author":"Huang","year":"2025","journal-title":"Eur Heart J Digit Health"},{"key":"2026051117354992000_xuag004-B141","doi-asserted-by":"publisher","first-page":"132979","DOI":"10.1016\/j.ijcard.2025.132979","article-title":"Artificial intelligence for left ventricular hypertrophy detection and differentiation on echocardiography, cardiac magnetic resonance and cardiac computed tomography: a systematic review","volume":"422","author":"Cirillo","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026051117354992000_xuag004-B142","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1097\/01.hjh.0000239305.01496.ca","article-title":"Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives","volume":"24","author":"Cuspidi","year":"2006","journal-title":"J Hypertens"},{"key":"2026051117354992000_xuag004-B143","doi-asserted-by":"publisher","first-page":"e009694","DOI":"10.1161\/CIRCHEARTFAILURE.122.009694","article-title":"Protein biomarkers of new-onset heart failure: insights from the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study","volume":"16","author":"Girerd","year":"2023","journal-title":"Circ Heart Fail"},{"key":"2026051117354992000_xuag004-B144","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1016\/j.jacc.2020.10.039","article-title":"Reliability of office, home, and ambulatory blood pressure measurements and correlation with left ventricular mass","volume":"76","author":"Schwartz","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026051117354992000_xuag004-B145","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41440-024-01905-2","article-title":"Ambulatory blood pressure is associated with left ventricular geometry after 10 years in hypertensive patients with continuous antihypertensive treatment","volume":"48","author":"Toba","year":"2025","journal-title":"Hypertens Res"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag004\/66396022\/xuag004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/28\/2\/217\/66396022\/xuag004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/28\/2\/217\/66396022\/xuag004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:35:58Z","timestamp":1778535358000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/28\/2\/217\/8424295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":145,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1,13]]},"published-print":{"date-parts":[[2026,5,11]]}},"URL":"https:\/\/doi.org\/10.1093\/ejhf\/xuag004","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,13]]}}}